🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The proposed study is a phase 1, open label, single arm study to evaluate t...
Status
Completed
Location
Weill Cornell Medicine, Cornell Clinical Trials Unit
Start Date
2022-12-07
Trial ID
NCT05245292
Treatments Being Tested
Open-label, Phase 1 Study of CD19 t-haNK as a Single Agent and in Combinati...
Status
Recruiting
Location
Hoag Memorial Hospital
Start Date
2025-08-22
Trial ID
NCT05618925
Treatments Being Tested
This research study is evaluating the safety and efficacy of a combination ...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2020-07-20
Trial ID
NCT04290546
Treatments Being Tested
This Phase 2 clinical trial is testing a new immunotherapy combination (N-8...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-12-15
Trial ID
NCT06765902
This study will test the safety and tolerability of Anktiva in patients wit...
Status
Recruiting
Location
University of California - San Francisco
Start Date
2025-11-14
Trial ID
NCT07108036
Treatments Being Tested
This is a phase I, randomized, open-label trial to investigate the safety o...
Status
Withdrawn
Location
Thai Red Cross AIDS Research Centre (TRCARC)
Start Date
2023-09-01
Trial ID
NCT05769569
Phase 2, single-arm study to evaluate combination therapy of avelumab, haNK...
Status
Terminated
Location
University of California San Francisco
Start Date
2020-02-19
Trial ID
NCT03853317
This is phase 2 single arm study evaluating the safety and preliminary effi...
Status
Recruiting
Location
Chan Soon-Shiong Institute for Medicine
Start Date
2024-11-06
Trial ID
NCT06710288
Treatments Being Tested
Background: Endometrial cancer (EC) of the uterus is becoming more common ...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2024-05-14
Trial ID
NCT06253494
Treatments Being Tested
Background: Biochemically recurrent prostate cancer (BCR) occurs when pros...
Status
Not Yet Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2026-08-26
Trial ID
NCT07686380
Treatments Being Tested